Medical Health & Life Science Research News

Recent research: Global in vitro fertilization market forecasts 2014-2022

Recent research: Global in vitro fertilization market forecasts 2014-2022

Big Market Research added a report on “Europe In Vitro Fertilization (IVF) Market By Cycle Type (Fresh Cycle, Thawed IVF Cycle, And Donor Egg IVF Cycle) And End User (Fertility Clinics, Hospitals, Surgical Centers, And Clinical Research Institutes) - Opportunity Analysis And Industry Forecast, 2014-2022”

- Advertising -

The European IVF market is expected to reach $4,447 million in 2022 growing at a CAGR of 5.4%, from $3,054 million in 2015. Delayed pregnancy in women is a major factor that drives the European market, as the chances of conceiving lowers with age and the success rate of getting pregnant via in vitro fertilization reduces with increase in age.

Other factors that accelerate the market growth are rise in infertility rate due to increase in stress levels, change in lifestyle, and fertility-related diseases.

Request for Sample [email protected] www.bigmarketresearch.com/request-sample/887168

In Europe, government regulations are favorable towards IVF treatments.

- Advertising -

The presence of regulatory and reimbursement policies such as three-parent IVF treatments and Human Fertilization and Embryo Authority (HFEA) guidelines contribute to high market growth.

IVF treatments have been criticized across various regions on ethical grounds. For instance, few incidences have been reported in the past for mixing-up of embryos.

Hence, the HFEA, which closely regulates the IVF treatments and research in UK, adopted the double-witness system to minimize chances of embryo mix-up in clinics. However, lack of reimbursements in Russia is expected to limit the growth of the Russian IVF market during the forecast period.

For Report [email protected] www.bigmarketresearch.com/purchase-enquiry/887168

KEY BENEFITS FOR STAKEHOLDERS

This report provides an in-depth analysis of the European IVF market across eight major countries along with cross-sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.

It includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the market.

The projections are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2014 to 2022.

Extensive analysis of the market is conducted by monitoring the top contenders.

KEY MARKET SEGMENTATION

By End User (Value and Volume)

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Cycle Type (Value and Volume)

  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • Donor Egg IVF Cycle

By Cycle Type Country Level Analysis (Value and Volume)

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia

Key Players

  • Thermo Fisher Scientific, Inc.
  • DRK Kliniken Berlin
  • Sun Pharmaceutical Industries Ltd.
  • Cadila Healthcare Ltd.
  • LG Life Sciences
  • EMD Serono Inc.

News From

Big Market Research - Market Research ReportsBig Market Research
Category: Market Research Publishers and RetailersCompany profile: With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market ...